Description
An alkaloid with diverse biological activities; inhibits CYP2D6 and CYP3A4 in vitro (Kis = 54 and 355 μM, respectively); reduces ZIKV NS1 protein expression in HEK293 cells (IC50 = 26.4 nM); reduces viral titer in ZIKV-infected SNB-19 cells (IC50 = 3.11 nM); reduces serum viral load in ZIKV-infected Ifnar1-/- mice at 2 mg/kg; induces emesis in ferrets at 0.5 mg/kg; increases output of respiratory tract fluid in rabbits at 1 mg/kg
Formal name: (1R)-1-[[(2S,3R,11bS)-3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]quinolizin-2-yl]methyl]-1,2,3,4-tetrahydro-7-methoxy-6-isoquinolinol
Synonyms: (-)-Cephaeline
Molecular weight: 466.6
CAS: 483-17-0
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Natural Products|Alkaloids||Product Type|Biochemicals|Small Molecule Inhibitors|Cytochrome P450||Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Zika||Research Area|Neuroscience